GVS produces microfilters for the medical, pharmaceutical, automotive and industrial sectors, operating as a B2B player. At the time of MCP divestment, the company commercialized over 200 different products produced in 10 plants located in Italy, Romania, England, Brazil, the United States and China. Most of the revenues generated by GVS were sourced from abroad, with sales offices in Europe, South America, Japan and Korea. During its holding period, MCP introduced GVS to one of the most important Chinese distributors of pharmaceutical and medical products, establishing a productive business partnership.

Website:
www.gvs.com